Orthogate Subspecialty Journal Scan: Spine Surgery & Reconstruction

Curated critical appraisals of recent practice-changing Level-I trials and systematic evidence across spine surgery, evaluating triangular titanium implants for pelvic fixation failure in adult deformity, viable cellular bone graft options in lumbar arthrodesis, and long-term functional outcomes of operative versus nonoperative management in cervical radiculopathy.

Featured Spine Studies This Week (September 2026)
Spine Deformity & Pelvic Fixation

1. Placement of Triangular Titanium Implants Suprajacent to Pelvic Fixation Screws Reduces Pelvic Fixation Failure in Multilevel Spinal Fusion: Results of a Randomized Controlled Trial

Authors: Elder B, Mundis G, Eastlack R, Arrigoni P, Franke J et al. | Journal: The Journal of Bone and Joint Surgery (Am) (Jul 2026) | View Source / DOI

Situation

Achieving durable spinopelvic fixation is the primary structural challenge in long-segment adult spinal deformity (ASD) surgery terminating at the sacrum. Traditional S2-alar-iliac (S2AI) pelvic screws withstand immense cantilever forces across the lumbosacral junction, but radiographic construct failure (screw loosening, haloing, pullout, or rod fracture distal to S1) remains unacceptably prevalent. This multicentre randomized trial assesses whether placing triangular titanium implants (TTI) suprajacent to S2AI screws enhances biomechanical load-sharing and prevents pelvic fixation failure.

Background

Pseudarthrosis at L5-S1 and mechanical hardware failure at the pelvic foundation represent the leading causes of revision surgery in adult deformity patients. While S2AI screws offer lower implant prominence and superior cortical bone purchase relative to historical iliac bolts, repetitive cyclical flexion-extension moments frequently induce sacroiliac joint micro-motion and screw fatigue. Triangular titanium porous implants were engineered to achieve rapid SI joint arthrodesis and anterior-column load sharing, yet prospective Level-I evidence on their adjunctive protective efficacy was lacking.

Assessment & Findings
  • Design & Cohort: Prospective, multicentre, international, partially blinded randomized controlled trial enrolling 222 patients undergoing multilevel spinal fusion with S2AI-based pelvic fixation. Subjects were randomized 1:1 to pelvic fixation using S2AI screws alone (mean age 64.8 years, 58.4% female) versus S2AI screws plus suprajacent triangular titanium implants (S2AI+TTI; mean age 64.9 years, 54.1% female). Patients underwent 24-month radiographic and high-resolution thin-cut CT assessment adjudicated by an independent blinded core laboratory.
  • Primary Findings: The primary composite radiographic endpoint (S2AI screw breakage, lucency, pullout, or posterior spinal rod breakage distal to S1) was cut nearly in half in the S2AI+TTI cohort compared to S2AI alone (11.0% vs 20.4%, p = 0.0415). Individual subcomponents, including screw haloing and screw fracture, occurred significantly less frequently with adjunctive TTI placement.
  • Complications & Alignment: Adjunctive TTI placement did not alter sagittal or coronal spinal alignment parameters. Overall spinal rod fracture rates across the entire construct did not differ significantly between cohorts (9.2% in S2AI+TTI vs 5.3% in S2AI alone, p = 0.197). No neurological, visceral, or vascular complications were attributable to suprajacent triangular implant placement.
Recommendation & Practice Takeaway

Clinical Pearl: Placing triangular titanium implants directly suprajacent to S2AI screws provides vital biomechanical load-sharing across the sacroiliac joint, cutting 2-year pelvic foundation failure rates by nearly 50% (11.0% vs 20.4%). Attending spine deformity surgeons should strongly consider incorporating suprajacent TTI into their pelvic anchor strategy, particularly in high-risk adult deformity patients with poor bone mineral density, elevated BMI, or high pelvic incidence where cantilever stresses across S1-S2 are maximal.

Lumbar Arthrodesis & Biologics

2. Comparison of Posterior Cellular Bonegraft Options for Single-Level Lumbar Spinal Fusion: A Randomized Trial

Authors: Buttermann G | Journal: The Spine Journal (Oct 2026) | View Source / DOI

Situation

Selecting the optimal osteoinductive bone graft material for posterior spinal fusion (PSF) in combined anterior/posterior lumbar surgery requires balancing fusion potency, donor-site morbidity, and institutional expense. While iliac bone graft (IBG) and bone morphogenetic protein (BMP) remain clinical benchmarks, commercial cellular allografts containing viable mesenchymal stem cells (MSCs) are heavily marketed as safer, osteoinductive substitutes. This prospective randomized study evaluates 6 graft alternatives to establish true CT-verified fusion rates and clinical outcomes.

Background

Autologous iliac bone harvesting carries documented risks of chronic donor-site pain, hematoma, and infection, whereas rhBMP-2 is expensive and entails risks of heterotopic ossification and radicular seroma when used in the posterior elements. Cellular allografts derived from bone marrow, adipose tissue, or amniotic fluid claim to provide osteogenic and osteoinductive properties without harvest morbidity. However, prospective head-to-head randomized trials with thin-cut CT verification comparing viable cellular allografts against autologous bone marrow aspirate (BMA) and BMP have been scarce.

Assessment & Findings
  • Design & Cohort: Prospective, single-blinded randomized study enrolling 175 consecutive patients undergoing elective 1-level anterior/posterior lumbar spinal fusion (ASF/PSF). Patients were randomized to 1 of 6 posterior bone graft cohorts: autologous iliac bone graft (IBG), BMP, concentrated autologous bone marrow aspirate (BMA) + cancellous allograft, bone marrow-derived cellular allograft (cAlloBone), adipose-derived cellular allograft (cAlloFat), or amnion-derived cellular allograft (cAlloAm), referenced against an inert cancellous allograft historical control (Allo). All cohorts had prospective outcomes followed for a minimum of 2 years with 1-year thin-cut CT adjudicated by blinded radiologists.
  • Radiographic Fusion Rates: Solid anterior interbody fusion (ASF) was achieved in 97.1% (170/175) of patients. Posterior spinal fusion (PSF) rates on CT revealed marked biological hierarchy: 98% for IBG, 94% for BMP, 85% for autologous BMA, 67% for cAlloBone, 64% for cAlloFat, 62% for cAlloAm, and 50% for inert allograft control. Commercial cellular allografts achieved significantly lower fusion rates than autologous BMA, BMP, or IBG.
  • Clinical Outcomes & Value: Despite divergent posterior CT fusion rates, patient-reported outcomes (VAS back and leg pain, Oswestry Disability Index [ODI], pain medication cessation) improved significantly and equally across all cohorts with no between-group differences, provided the anterior interbody fusion was solid. BMP was the most expensive graft material, whereas proprietary cellular allografts had a high cost relative to their modest fusion efficacy.
Recommendation & Practice Takeaway

Clinical Pearl: Commercial viable cellular allografts exhibit disappointing posterior fusion rates (62% to 67%), only marginally outperforming inert allograft (50%) and falling well short of autologous BMA (85%), BMP (94%), and iliac autograft (98%). When a solid anterior interbody fusion is achieved, clinical PROMs improve uniformly regardless of posterior graft selection. Spine surgeons and hospital value analysis committees should avoid the high premium of proprietary cellular allografts: autologous bone marrow aspirate combined with allograft delivers superior fusion biology at a fraction of the cost.

Cervical Spine & Clinical Decision-Making

3. Nonoperative Management is Associated With Similar Long-Term Patient-Reported Outcomes Compared With Surgery for Cervical Radiculopathy: A Systematic Review and Meta-analysis

Authors: Kale K, Chai Y, Patel S, Nischal S, Wilson J | Journal: Spine (Oct 2026) | View Source / DOI

Situation

Cervical radiculopathy resulting from disc herniation or spondylotic foraminal stenosis is a major cause of neck and radiating upper extremity pain. While surgical decompression (ACDF, cervical disc arthroplasty, or posterior foraminotomy) provides reliable acute symptom relief, whether operative treatment confers durable long-term functional advantages over structured nonoperative care remains one of the most critical clinical controversies in spinal surgery.

Background

Current practice variations lead many patients with cervical radiculopathy to undergo early surgical intervention, often driven by patient discomfort and expectations of permanent relief. Nonoperative protocols, including structured physiotherapy, cervical traction, multimodal analgesics, and selective epidural steroid injections, have demonstrated favorable natural histories. However, pooled comparative evidence synthesizing long-term (>12 months) functional outcomes, disability, and analgesia dependence has been needed to guide shared decision-making.

Assessment & Findings
  • Design & Cohort: Systematic review and meta-analysis adhering to PRISMA guidelines, searching PubMed, Embase, and the Cochrane Library from inception to January 2026. Eleven comparative clinical studies comprising 1,154 patients (surgical decompression: n = 522; structured nonoperative management: n = 632) were included. Primary endpoints were visual analog scale (VAS) scores for arm and neck pain, Neck Disability Index (NDI), and overall clinical success at >=12 months post-intervention. Random-effects meta-analyses were conducted using restricted maximum likelihood estimation.
  • Primary Outcomes at >=12 Months: Surgical intervention was not associated with statistically significant or clinically meaningful superior long-term outcomes in VAS arm pain (mean difference [MD]: -0.67, 95% CI: -1.59 to 0.26, p = 0.12), VAS neck pain (MD: -0.50, 95% CI: -1.38 to 0.38, p = 0.19), or Neck Disability Index (MD: -3.69, 95% CI: -9.63 to 2.25, p = 0.16). Overall clinical success rates were equivalent between surgical and conservative care (risk ratio [RR]: 1.11, 95% CI: 0.93 to 1.34, p = 0.21).
  • Secondary Endpoints: No significant differences were observed between cohorts in long-term analgesia/opioid utilization (p = 0.54) or total duration of sick leave from work (p = 0.48). Evidence certainty across studies was rated moderate under GRADE criteria.
Recommendation & Practice Takeaway

Clinical Pearl: In cervical radiculopathy without progressive neurological deficit or cervical myelopathy, long-term pain, disability, and work resumption outcomes are clinically indistinguishable between surgical decompression and structured nonoperative therapy. While surgery remains invaluable for achieving rapid acute pain relief in refractory presentations, attending spine surgeons can confidently counsel patients that thorough conservative care is biologically durable and safe, avoiding routine early operative risks and adjacent segment disease.

Orthogate Weekly Journal Scan is curated and synthesized by ORION (Orthopaedic Research, Intelligence & Operations Navigator) for orthopaedic surgeons, fellows, and residents. Evidence synthesized under the clinical direction of Christian Veillette, MD, MSc, FRCSC.